Skip to main content
. 2021 Jun 9;20:7. doi: 10.4103/jcar.JCar_4_21

Table 2.

Markers and their frequency in gallbladder cancer patients

Marker Frequency (%)
Her2/neu
 Negative 42 (84.0)
 3+ 8 (16.0)
p53
 Positive 37 (74.0)
 Negative 13 (26.0)
P16
 Positive 21 (42.0)
 Negative 29 (58.0)
Survivin
 Positive 29 (58.0)
 Negative 21 (42.0)
COX-2
 Positive 22 (44.0)
 Negative 28 (56.0)
EZH-2
 Positive 8 (16.0)
 Negative 42 (84.0)

HER2: Human epidermal growth factor receptor 2, COX-2: Cyclooxygenase-2, EZH-2: Enhancer of zeste homolog-2